Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Sol-Gel Technologies
(NASDAQ:SLGL)
Intraday
$0.975
0.055
[5.98%]
After-Hours
$0.975
0
[0.00%]
Get Report
Watch
Perks
Buy
Compare Brokers
$0.975
0.055
[5.98%]
At close: Apr 22
$0.975
0
[0.00%]
PreMarket: 8:47AM EDT
Get Report
Watch
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Sol-Gel Technologies Stock (NASDAQ:SLGL)
Sol-Gel Technologies Stock (NASDAQ: SLGL)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Monday, April 01, 2024
Sol-Gel's Collaboration Partner First-To-File ANDA Drug Product Generic To Zoryve Cream Indicated For Plaque Psoriasis In Patients Six Years Of Age And Older
Benzinga Newsdesk
-
Apr 1, 2024, 7:19AM
Wednesday, March 13, 2024
Sol-Gel Technologies: Q4 Earnings Insights
Benzinga Insights
-
Mar 13, 2024, 9:40AM
Sol-Gel Technologies Posts FY23 Revenue Of $1.6M and EPS Of $(1.01).
Benzinga Newsdesk
-
Mar 13, 2024, 7:13AM
Tuesday, November 28, 2023
Sol-Gel Technologies Ltd To Host Virtual KOL Event On Gorlin Syndrome And The Upcoming Phase 3 Trial For SGT-610
Benzinga Newsdesk
-
Nov 28, 2023, 8:21AM
Monday, November 13, 2023
HC Wainwright & Co. Maintains Buy on Sol-Gel Technologies, Lowers Price Target to $9
Benzinga Newsdesk
-
Nov 13, 2023, 11:25AM
Thursday, November 09, 2023
Sol-Gel Technologies Q3 EPS $(0.21) Beats $(0.23) Estimate, Sales $213.00K Miss $690.00K Estimate
Benzinga Newsdesk
-
Nov 9, 2023, 7:51AM
Recap: Sol-Gel Technologies Q3 Earnings
Benzinga Insights
-
Nov 9, 2023, 7:30AM
Thursday, October 05, 2023
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
-
Oct 5, 2023, 1:22PM
Wednesday, October 04, 2023
Stocks That Hit 52-Week Lows On Wednesday
Benzinga Insights
-
Oct 4, 2023, 12:01PM
Tuesday, October 03, 2023
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
-
Oct 3, 2023, 2:37PM
Friday, September 29, 2023
Stocks That Hit 52-Week Lows On Friday
Benzinga Insights
-
Sep 29, 2023, 2:09PM
Thursday, September 28, 2023
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
-
Sep 28, 2023, 2:32PM
Tuesday, September 26, 2023
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
-
Sep 26, 2023, 12:04PM
Friday, September 15, 2023
Stocks That Hit 52-Week Lows On Friday
Benzinga Insights
-
Sep 15, 2023, 11:52AM
Monday, August 14, 2023
HC Wainwright & Co. Maintains Buy on Sol-Gel Technologies, Lowers Price Target to $12
Benzinga Newsdesk
-
Aug 14, 2023, 6:24AM
Friday, August 11, 2023
Expert Ratings for Sol-Gel Technologies
Benzinga Insights
-
Aug 11, 2023, 3:00PM
Raymond James Maintains Strong Buy on Sol-Gel Technologies, Lowers Price Target to $7
Benzinga Newsdesk
-
Aug 11, 2023, 8:24AM
Monday, July 24, 2023
HC Wainwright & Co. Reiterates Buy on Sol-Gel Technologies, Maintains $19 Price Target
Benzinga Newsdesk
-
Jul 24, 2023, 6:41AM
Wednesday, July 19, 2023
Raymond James Maintains Strong Buy on Sol-Gel Technologies, Lowers Price Target to $9
Benzinga Newsdesk
-
Jul 19, 2023, 7:27AM
Tuesday, June 06, 2023
Sol-Gel And Searchlight Pharma Announce Licensing Agreements To Commercialize TWYNEO And EPSOLAY In Canada; Sol-Gel To Receive Up To $11M In Upfront Payments And Milestones Plus Additional Royalties From Low Double-Digits to High-Teens
Benzinga Newsdesk
-
Jun 6, 2023, 7:08AM
Monday, June 05, 2023
HC Wainwright & Co. Reiterates Buy on Sol-Gel Technologies, Maintains $19 Price Target
Benzinga Newsdesk
-
Jun 5, 2023, 6:09AM
Wednesday, April 12, 2023
HC Wainwright & Co. Reiterates Buy on Sol-Gel Technologies, Maintains $19 Price Target
Benzinga Newsdesk
-
Apr 12, 2023, 6:13AM
Wednesday, March 22, 2023
Why Edible Garden Shares Are Trading Lower By Over 26%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Lisa Levin
-
Mar 22, 2023, 1:56PM
Tuesday, March 14, 2023
Raymond James Maintains Strong Buy on Sol-Gel Technologies, Lowers Price Target to $10
Benzinga Newsdesk
-
Mar 14, 2023, 7:30AM
Wednesday, February 01, 2023
HC Wainwright & Co. Reiterates Buy on Sol-Gel Technologies, Maintains $19 Price Target
Benzinga Newsdesk
-
Feb 1, 2023, 6:09AM
Friday, January 27, 2023
Sol-Gel Announces Aggregate $22.8M Concurrent Registered Direct And Private Placement Offerings
Bill Haddad
-
Jan 27, 2023, 7:30AM
Sol-Gel Acquires Orphan Drug Candidate Patidegib; Co. To Pay PellePharm $4.7M Up Front, Up To $6M in NDA Acceptance Milestones Ad Up To $64M In Commercial Milestones
Bill Haddad
-
Jan 27, 2023, 7:08AM
Monday, November 14, 2022
Heska To $165? Plus BTIG Cuts PT On This Stock By 67%
Lisa Levin
-
Nov 14, 2022, 8:21AM
HC Wainwright & Co. Maintains Buy on Sol-Gel Technologies, Lowers Price Target to $19
Benzinga Newsdesk
-
Nov 14, 2022, 6:30AM
Friday, November 11, 2022
Raymond James Maintains Strong Buy on Sol-Gel Technologies, Lowers Price Target to $13
Benzinga Newsdesk
-
Nov 11, 2022, 7:42AM
Thursday, November 10, 2022
Sol-Gel Technologies Q3 EPS $(0.15) Misses $(0.07) Estimate, Sales $261.00K Miss $3.42M Estimate
Benzinga Newsdesk
-
Nov 10, 2022, 7:35AM
Monday, November 07, 2022
What Does Sunshine Biopharma's Acquisition Of Nora Pharma Mean For The Generic Prescription Drugs Market?
Ernest Dela Aglanu
-
Sponsored
Monday, October 24, 2022
Nasdaq Turns Higher; Applied Genetic Technologies Shares Surge
Lisa Levin
-
Oct 24, 2022, 12:23PM
Friday, October 21, 2022
Benzinga's Top Ratings Upgrades, Downgrades For October 21, 2022
Benzinga Insights
-
Oct 21, 2022, 10:11AM
Jefferies Initiates Coverage On Sol-Gel Technologies with Hold Rating, Announces Price Target of $5.5
Benzinga Newsdesk
-
Oct 21, 2022, 8:49AM
Monday, August 29, 2022
HC Wainwright & Co. Maintains Buy on Sol-Gel Technologies, Raises Price Target to $22
Benzinga Newsdesk
-
Aug 29, 2022, 6:15AM
Thursday, August 04, 2022
Sol-Gel Technologies Q2 EPS $(0.25) Up From $(0.35) YoY
Benzinga Newsdesk
-
Aug 4, 2022, 6:24AM
Monday, July 18, 2022
Why Bank Stocks Traded Sharply Higher; Here Are 65 Biggest Movers From Friday
Lisa Levin
-
Jul 18, 2022, 5:43AM
Friday, July 15, 2022
Citigroup, Bank of America And 48 Stocks Moving In Friday's Mid-Day Session
Lisa Levin
-
Jul 15, 2022, 12:11PM
Thursday, June 30, 2022
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
-
Jun 30, 2022, 12:05PM
Wednesday, June 29, 2022
Why Is Allena Pharmaceuticals Jumping By 207%? 45 Stocks Moving In Wednesday's Mid-Day Session
Lisa Levin
-
Jun 29, 2022, 12:32PM
Wednesday, June 22, 2022
Stocks That Hit 52-Week Lows On Wednesday
Benzinga Insights
-
Jun 22, 2022, 12:30PM
Monday, May 16, 2022
Raymond James Maintains Strong Buy on Sol-Gel Technologies, Lowers Price Target to $16
Benzinga Newsdesk
-
May 16, 2022, 7:38AM
Friday, May 13, 2022
Sol-Gel Technologies: Q1 Earnings Insights
Benzinga Insights
-
May 13, 2022, 9:05AM
Sol-Gel Technologies Q1 Loss $5.6M vs Loss $4.1M In Same Qtr. Last Year
Benzinga Newsdesk
-
May 13, 2022, 7:12AM
Monday, April 25, 2022
HC Wainwright & Co. Maintains Buy on Sol-Gel Technologies, Raises Price Target to $21
Benzinga Newsdesk
-
Apr 25, 2022, 11:19AM
Sol-Gel Technologies And Galderma Announce FDA Approval Of EPSOLAY
Benzinga Newsdesk
-
Apr 25, 2022, 7:10AM
Tuesday, April 19, 2022
Sol-Gel Technologies Filing Shows Registration Statement For $23M Offering Of Common Stock Via Selling Shareholders
Benzinga Newsdesk
-
Apr 19, 2022, 4:07PM
Friday, April 01, 2022
Raymond James Maintains Strong Buy on Sol-Gel Technologies, Lowers Price Target to $17
Benzinga Newsdesk
-
Apr 1, 2022, 7:29AM
Wednesday, March 30, 2022
Sol-Gel Technologies FY21 Sales $31.3M
Bill Haddad
-
Mar 30, 2022, 7:17AM
Show more